Literature DB >> 25905960

Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma.

Satoshi Goshima1, Masayuki Kanematsu, Yoshifumi Noda, Hiroshi Kondo, Haruo Watanabe, Kyongtae T Bae.   

Abstract

OBJECTIVE: The objective of our study was to compare diffusion kurtosis imaging (DKI) with conventional diffusion-weighted imaging (DWI) for assessing the response to treatment in hypervascular hepatocellular carcinoma (HCC). SUBJECTS AND METHODS: Sixty-two consecutive patients with treated or untreated hypervascular HCC underwent MRI of the liver including DKI (b values of 0, 100, 500, 1000, 1500, and 2000 s/mm(2)). The mean kurtosis (MK) and apparent diffusion coefficient (ADC) values of the hepatic parenchyma and of the HCCs were computed. The detectability of viable HCC based on MK and ADC values was compared. We also assessed the correlation between Child-Pugh grades and MK or ADC values.
RESULTS: For a total of 112 HCC nodules (viable, n = 63; nonviable, n = 49), the MK value was significantly higher for the viable group (mean ± SD, 0.81 ± 0.11) than for the non-viable group (0.57 ± 0.11) (p < 0.001). The mean ADC value was significantly lower for the viable group (1.44 ± 0.42 × 10(-3) mm(2)/s) than for the nonviable group (1.94 ± 0.52 × 10(-3) mm(2)/s) (p < 0.001). The sensitivity, specificity, and AUC of the ROC curve for the assessment of HCC viability were greater (p < 0.001) using MK (85.7%, 98.0%, and 0.95, respectively; cutoff value = 0.710) than using ADC (79.6%, 68.3%, and 0.77, respectively; cutoff value = 1.535 × 10(-3) mm(2)/s). Although the ADC of hepatic parenchyma was lower in patients with Child-Pugh grade B or C disease than in those with grade A disease (p = 0.02), no significant difference in MK (p = 0.45) was found among the Child-Pugh grades.
CONCLUSION: DKI can be a new option for the assessment of posttherapeutic response in HCC.

Entities:  

Keywords:  HCC; MRI; diffusion; hepatocellular carcinoma; kurtosis; liver

Mesh:

Year:  2015        PMID: 25905960     DOI: 10.2214/AJR.14.13235

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  28 in total

Review 1.  Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others.

Authors:  Mecit Kantarci; Berhan Pirimoglu
Journal:  J Gastrointest Cancer       Date:  2017-09

2.  Staging liver fibrosis with DWI: is there an added value for diffusion kurtosis imaging?

Authors:  Li Yang; Shengxiang Rao; Wentao Wang; Caizhong Chen; Ying Ding; Chun Yang; Robert Grimm; Xu Yan; Caixia Fu; Mengsu Zeng
Journal:  Eur Radiol       Date:  2018-01-30       Impact factor: 5.315

Review 3.  Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Ke Yang; Xiao-Ming Zhang; Lin Yang; Hao Xu; Juan Peng
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

4.  Whole-tumour diffusion kurtosis MR imaging histogram analysis of rectal adenocarcinoma: Correlation with clinical pathologic prognostic factors.

Authors:  Yanfen Cui; Xiaotang Yang; Xiaosong Du; Zhizheng Zhuo; Lei Xin; Xintao Cheng
Journal:  Eur Radiol       Date:  2017-10-23       Impact factor: 5.315

5.  Diffusion kurtosis imaging (DKI) of hepatocellular carcinoma: correlation with microvascular invasion and histologic grade.

Authors:  Likun Cao; Jie Chen; Ting Duan; Min Wang; Hanyu Jiang; Yi Wei; Chunchao Xia; Xiaoyue Zhou; Xu Yan; Bin Song
Journal:  Quant Imaging Med Surg       Date:  2019-04

6.  Measurement of cellular-interstitial water exchange time in tumors based on diffusion-time-dependent diffusional kurtosis imaging.

Authors:  Jin Zhang; Gregory Lemberskiy; Linda Moy; Els Fieremans; Dmitry S Novikov; Sungheon Gene Kim
Journal:  NMR Biomed       Date:  2021-02-25       Impact factor: 4.044

7.  Advances in Diffusion and Perfusion MRI for Quantitative Cancer Imaging.

Authors:  Mehran Baboli; Jin Zhang; Sungheon Gene Kim
Journal:  Curr Pathobiol Rep       Date:  2019-12-02

Review 8.  The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma.

Authors:  Kang Liu; Xu-Li Min; Juan Peng; Ke Yang; Lin Yang; Xiao-Ming Zhang
Journal:  J Clin Med Res       Date:  2016-02-27

9.  Evaluation of intratumoral heterogeneity by using diffusion kurtosis imaging and stretched exponential diffusion-weighted imaging in an orthotopic hepatocellular carcinoma xenograft model.

Authors:  Ran Guo; Shuo-Hui Yang; Fang Lu; Zhi-Hong Han; Xu Yan; Cai-Xia Fu; Meng-Long Zhao; Jiang Lin
Journal:  Quant Imaging Med Surg       Date:  2019-09

Review 10.  Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma.

Authors:  Vincenza Granata; Roberta Grassi; Roberta Fusco; Andrea Belli; Carmen Cutolo; Silvia Pradella; Giulia Grazzini; Michelearcangelo La Porta; Maria Chiara Brunese; Federica De Muzio; Alessandro Ottaiano; Antonio Avallone; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2021-07-19       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.